You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Diabetes and other endocrinal, nutritional and metabolic conditions
  5. Faltering growth

Human growth hormone (somatropin) for the treatment of growth failure in children

  • Technology appraisal guidance
  • Reference number: TA188
  • Published:  26 May 2010
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

TA188 Human growth hormone (somatropin) for the treatment of growth failure in children (review): Appendix B - proposal paper presented to the Institute's Guidance Executive

TA188 Human growth hormone (somatropin) for the treatment of growth failure in children (review): Appendix B - proposal paper presented to the Institute's Guidance Executive TA188 Human growth hormone (somatropin) for the treatment of growth failure in children (review): Appendix B - proposal paper presented to the Institute's Guidance Executive
21 May 2013
(457.97 Kb 13 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 17 May 2013

Back to top